283 related articles for article (PubMed ID: 15557157)
1. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis.
Reich-Zeliger S; Gan J; Bachar-Lustig E; Reisner Y
J Immunol; 2004 Dec; 173(11):6660-6. PubMed ID: 15557157
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
Rich RF; Green WR
J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
[TBL] [Abstract][Full Text] [Related]
3. Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite.
Reich-Zeliger S; Zhao Y; Krauthgamer R; Bachar-Lustig E; Reisner Y
Immunity; 2000 Oct; 13(4):507-15. PubMed ID: 11070169
[TBL] [Abstract][Full Text] [Related]
4. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells.
Reich-Zeliger S; Bachar-Lustig E; Gan J; Reisner Y
J Immunol; 2004 Dec; 173(11):6654-9. PubMed ID: 15557156
[TBL] [Abstract][Full Text] [Related]
5. Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylation.
Reich-Zeliger S; Eidelstein Y; Hagin D; Antebi YE; Seger R; Reisner Y
Transplantation; 2010 Aug; 90(4):380-6. PubMed ID: 20595932
[TBL] [Abstract][Full Text] [Related]
6. Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cells.
Reich-Zeliger S; Bachar-Lustig E; Bar-Ilan A; Reisner Y
J Immunol; 2007 Nov; 179(10):6389-94. PubMed ID: 17982025
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TCR-induced CD8 T cell death by IL-12: regulation of Fas ligand and cellular FLIP expression and caspase activation by IL-12.
Lee SW; Park Y; Yoo JK; Choi SY; Sung YC
J Immunol; 2003 Mar; 170(5):2456-60. PubMed ID: 12594270
[TBL] [Abstract][Full Text] [Related]
8. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver.
Liu ZX; Govindarajan S; Okamoto S; Dennert G
J Immunol; 2001 Mar; 166(5):3035-41. PubMed ID: 11207253
[TBL] [Abstract][Full Text] [Related]
9. Self-veto mechanism of CD8+ cytotoxic effector T cells. Peptide-induced paralysis affects the peptide-MHC-recognizing cytotoxic T lymphocytes and is independent of Fas/Fas ligand interactions.
Bergenthal A; Hofmann M; Heeg K
Eur J Immunol; 1998 Jun; 28(6):1911-22. PubMed ID: 9645373
[TBL] [Abstract][Full Text] [Related]
10. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
Teh HS; Seebaran A; Teh SJ
J Immunol; 2000 Nov; 165(9):4814-21. PubMed ID: 11046004
[TBL] [Abstract][Full Text] [Related]
11. Fas ligand is required for resolution of granulomatous experimental autoimmune thyroiditis.
Wei Y; Chen K; Sharp GC; Braley-Mullen H
J Immunol; 2004 Dec; 173(12):7615-21. PubMed ID: 15585889
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand costimulates the in vivo proliferation of CD8+ T cells.
Suzuki I; Martin S; Boursalian TE; Beers C; Fink PJ
J Immunol; 2000 Nov; 165(10):5537-43. PubMed ID: 11067907
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
Delgado M; Ganea D
J Immunol; 2000 Jul; 165(1):114-23. PubMed ID: 10861043
[TBL] [Abstract][Full Text] [Related]
14. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
15. Cellular FLIP (long form) regulates CD8+ T cell activation through caspase-8-dependent NF-kappa B activation.
Dohrman A; Kataoka T; Cuenin S; Russell JQ; Tschopp J; Budd RC
J Immunol; 2005 May; 174(9):5270-8. PubMed ID: 15843523
[TBL] [Abstract][Full Text] [Related]
16. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
Margenthaler JA; Flye MW
J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis of epitope-specific antiretroviral cytotoxic T lymphocytes via Fas ligand-Fas interactions.
Rich RF; Green WR
Viral Immunol; 2006; 19(3):424-33. PubMed ID: 16987061
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cells.
Anderson KM; Zimring JC
Transplantation; 2006 Jan; 81(1):88-94. PubMed ID: 16421482
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of thymidine synthesis by folate analogues induces a Fas-Fas ligand-independent deletion of superantigen-reactive peripheral T cells.
Izeradjene K; Revillard JP; Genestier L
Int Immunol; 2001 Jan; 13(1):85-93. PubMed ID: 11133837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
